A WCRI report explores telemedicine utilization.
WCRI explores how drug payments varied across 28 states for key drug therapy groups.
Less than 1% of gabapentin prescriptions were prescribed for an FDA-approved diagnosis.
A new WCRI report explores the impact recent opioid legislation has had on injured worker care.
Another WCRI report looks at non-COVID-19 claims with injuries in the first two quarters of 2019 and 2020.
A new flash report from the WCRI highlights trends in drug utilization.
Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.
While many states report fewer opioid prescriptions, MME levels vary more significantly by state.